GOLDFINCH BIO
Dead / Cancelled — Cancelled — Section 8 (as of 09 Jan 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87169128
- Registration number
- 5788169
- Mark type
- Stylized text
- Filed
- 13 Sept 2016
- Published for opposition
- 07 Feb 2017
- Registered
- 25 Jun 2019
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of renal diseases and disorders
Owner
- GFB (ABC), LLC, BELMAR, NJ, US
- GOLDFINCH BIO, INC., CAMBRIDGE, MA, US
- GOLDFINCH BIO, INC., CAMBRIDGE, MA, US
- Goldfinch Biopharma, Inc., Boston, MA, US
- Goldfinch Biopharma, Inc., Boston, MA, US
Prosecution history
- 09 Jan 2026 — CANCELLED SEC. 8 (6-YR)
- 25 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Feb 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 22 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 May 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2019 — USE AMENDMENT FILED
- 21 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 30 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2019 — SOU EXTENSION 4 GRANTED
- 28 Mar 2019 — SOU EXTENSION 4 FILED
- 28 Mar 2019 — SOU TEAS EXTENSION RECEIVED
- 13 Sept 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED